<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diabetic ketoacidosis in adults: Rapid overview of emergency management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diabetic ketoacidosis in adults: Rapid overview of emergency management</h1>
<div class="graphic"><div class="figure"><div class="ttl">Diabetic ketoacidosis in adults: Rapid overview of emergency management</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Clinical features </td> </tr> <tr> <td class="indent1">DKA usually evolves rapidly over a 24-hour period.</td> </tr> <tr> <td class="indent1">The earliest symptoms of marked hyperglycemia are polyuria, polydipsia, and weight loss. Common, early signs of ketoacidosis include nausea, vomiting, abdominal pain, and hyperventilation.</td> </tr> <tr> <td class="indent1">As hyperglycemia worsens, neurologic symptoms appear and may progress to include lethargy, focal deficits, obtundation, seizure, and coma.</td> </tr> <tr> <td class="indent1">Common causes of DKA include: infection; noncompliance, inappropriate adjustment, or cessation of insulin; new-onset diabetes mellitus; and myocardial ischemia.</td> </tr> <tr> <td class="subtitle1_single">Evaluation and laboratory findings</td> </tr> <tr> <td class="indent1">Assess vital signs, cardiorespiratory status, and mental status.</td> </tr> <tr> <td class="indent1">Assess volume status: vital signs, skin turgor, mucosa, urine output.</td> </tr> <tr> <td class="indent1">Obtain the following studies: serum glucose, urinalysis and urine ketones, serum electrolytes, BUN and creatinine, plasma osmolality, mixed venous blood gas, electrocardiogram; add serum ketones if urine ketones present.</td> </tr> <tr> <td class="indent1">DKA is characterized by hyperglycemia, an elevated anion gap* metabolic acidosis, and ketonemia. Dehydration and potassium deficits are often severe.</td> </tr> <tr> <td class="indent1">Serum glucose is usually greater than 250 mg/dL (13.9 mmol/L) and less than 800 mg/dL (44.4 mmol/L). In certain instances (eg, insulin given prior to emergency department arrival), the glucose may be only mildly elevated.</td> </tr> <tr> <td class="indent1">Additional testing is obtained based on clinical circumstances and may include: blood or urine cultures, lipase, chest radiograph.</td> </tr> <tr> <td class="subtitle1_single">Management</td> </tr> <tr> <td class="indent1">Stabilize the patient's airway, breathing, and circulation.</td> </tr> <tr> <td class="indent1">Obtain large bore IV (≥16 gauge) access; monitor using a cardiac monitor, capnography, and pulse oximetry.</td> </tr> <tr> <td class="indent1">Monitor serum glucose hourly, and basic electrolytes and venous pH or bicarbonate every two to four hours until the patient is stable.</td> </tr> <tr> <td class="indent1">Determine and treat any underlying cause of DKA (eg, pneumonia or urinary infection, myocardial ischemia).</td> </tr> <tr> <td class="subtitle2_single">Replete ECF volume and free water deficits: </td> </tr> <tr> <td class="indent2"> <ul> <li>Give several liters of IV isotonic (0.9%) saline as rapidly as possible to patients with signs of shock.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>Give IV isotonic (0.9%) saline at 15 to 20 mL/kg per hour (ie, 1 to 1.5 L per hour for an average-sized adult), in the absence of cardiac compromise, for the first few hours to hypovolemic patients without shock. </li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>After intravascular volume is restored, give one-half isotonic (0.45%) saline at 4 to 14 mL/kg per hour if the corrected serum Na+<sup>¶</sup> is normal or elevated; isotonic saline is continued if the corrected serum Na+<sup>¶</sup> is reduced.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>Add dextrose to the saline solution when the serum glucose reaches ~200 mg/dL (11.1 mmol/L).</li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Replete potassium (K+) deficits: </td> </tr> <tr> <td class="indent2"> <ul> <li>Regardless of the initial measured serum K+, patients with DKA have a large total body K+ deficit.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>Manage replacement based on initial serum K+ value:</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <ul> <li>&lt;3.3 mEq/L – Hold insulin and give potassium chloride 20 to 40 mEq/hour IV until K+ concentration is above 3.3 mEq/L; rarely, additional potassium supplementation may be necessary to avoid life-threatening muscle weakness and cardiac arrhythmias.</li> </ul> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <ul> <li>3.3 to 5.3 mEq/L – Give potassium chloride 20 to 30 mEq per liter IV fluid; maintain serum K+ between 4 to 5 mEq/L.</li> </ul> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <ul> <li>&gt;5.3 mEq/L – Do not give potassium; check serum K+ every 2 hours; delay administration of potassium chloride until serum K+ has fallen to 5 to 5.2 mEq/L.</li> </ul> </ul> </td> </tr> <tr> <td class="subtitle2_single">Give insulin:</td> </tr> <tr> <td class="indent2"> <ul> <li>For patients with K+ &lt;3.3 mEq/L, do <strong>not</strong> give insulin; replete K+ and fluid deficit first.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>For patients with K+ ≥3.3 mEq/L, give regular insulin. Either of 2 regimens can be used: 0.1 units/kg IV bolus, then start a continuous IV infusion 0.1 units/kg per hour; <strong>or</strong> do not give bolus and start a continuous IV infusion at a rate of 0.14 units/kg per hour.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>If serum glucose does not fall by at least 50 to 70 mg/dL (2.8 to 3.9 mmol/L) in the first hour, double the rate of insulin infusion.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>When the serum glucose reaches 200 mg/dL (11.1 mmol/L), it may be possible to decrease the infusion rate to 0.02 to 0.05 units/kg per hour.</li> </ul> </td> </tr> <tr> <td class="indent2"> <ul> <li>Continue insulin infusion until ketoacidosis is resolved, serum glucose is below 200 mg/dL (11.1 mmol/L), and subcutaneous insulin is begun.</li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Give sodium bicarbonate to patients with pH below 6.90:</td> </tr> <tr> <td class="indent2"> <ul> <li>If the arterial pH is below 6.90, give 100 mEq of sodium bicarbonate plus 20 mEq of potassium chloride in 400 mL sterile water over two hours; may be repeated if venous pH remains below 7.00.</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>DKA: diabetic ketoacidosis; BUN: blood urea nitrogen; IV: intravenous; ECF: extracellular fluid; Na: sodium; K: potassium.</p>
<p>* Patients with DKA usually present with a serum anion gap greater than 20 mEq/L (normal range approximately 3 to 10 mEq/L). However, the increase in anion gap is variable, being determined by several factors: the rate and duration of ketoacid production, the rate of metabolism of the ketoacids and their loss in the urine, and the volume of distribution of the ketoacid anions.</p>
	
	¶ Serum Na+ should be corrected for hyperglycemia; for each 100 mg/dL serum glucose exceeds 100 mg/dL (5.5 mmol/L), add 2 mEq to plasma Na+ for correction of Na+ value for hyperglycemia. A calculator to determine serum Na+ corrected for hyperglycemia is available separately in UpToDate.</div><div id="graphicVersion">Graphic 57723 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
